The nasal tissues are exposed to the highest levels of air-borne xenobiotics of any body tissue, and mammalian olfactory mucosa is remarkably active int he metabolism of xenobiotics. The molecular mechanism underlying such high metabolic activity is not fully understood although the presence of high levels and unique forms of P450 has been demonstrated. P450NMa (NMa), one of the major P450s in rabbit nasal microsomes, is highly active in the metabolic activation of many known nasal toxicants and procarcinogens, including N-nitrosodiethylamine,4- (methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), phenacetin, hexamethylphosphoramide, 2,6-dichlorobenzonitrile (DCBN), and aflatoxin B1 (AFB1). Nevertheless, the significance of the preferential expression of NMa in the nasal tissues in the tissue-specific toxicity of these xenobiotics in rodents and in risk assessment in humans is not conclusive, since most toxicity studies have been conducted in rodents and little is known about xenobiotic metabolism in human olfactory mucosa. Thus, my hypothesis is that P450s structurally similar to NMa are present in human and rodent olfactory tissues and play important roles in the metabolic activation of many olfactory toxicants.
My specific aims are: 1. Identification and cDNA cloning of P450 isozymes expressed in human and rat olfactory mucosa with particular emphasis on isoforms that are structurally similar to rabbit P450 2A10 and 2A11 (NMa); 2. Heterologous expression of rat and human 2A-related cDNAs (obtained in aim 1) in E. coli or COS1 cells, and examination of the activity of the recombinant and microsomal P450s in the bioactivation of two olfactory toxicants, DCBN (herbicide) and AFB1 (food contaminant); and 3. Immunochemical and molecular characterization of 2A-related P450 isozymes expressed in rat olfactory bulb so as to determine whether the central olfactory tissues are vulnerable to the toxicity associated with metabolic activation in situ. If time permits, olfactory expression of other P450 genes will be examined wand the role of rodent and human olfactory P450s in the metabolic activation or detoxification of additional toxicants will be studied. With a long-term objective of understanding the impact of environmental toxicants on the olfactory system, future studies will examine the likely genetic polymorphism of 2A-related olfactory P450s in human populations and the developmental expression of these and other P450s to explore the potential genetic predisposition and age-related vulnerability of the olfactory system to xenobiotic toxicity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
1R01ES007462-01
Application #
2156874
Study Section
Toxicology Subcommittee 2 (TOX)
Project Start
1994-09-15
Project End
1998-08-31
Budget Start
1994-09-15
Budget End
1995-08-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Wadsworth Center
Department
Type
DUNS #
110521739
City
Menands
State
NY
Country
United States
Zip Code
12204
Hu, Jinping; Sheng, Li; Li, Lei et al. (2014) Essential role of the cytochrome P450 enzyme CYP2A5 in olfactory mucosal toxicity of naphthalene. Drug Metab Dispos 42:23-7
Xie, Fang; Fang, Cheng; Schnittke, Nikolai et al. (2013) Mechanisms of permanent loss of olfactory receptor neurons induced by the herbicide 2,6-dichlorobenzonitrile: effects on stem cells and noninvolvement of acute induction of the inflammatory cytokine IL-6. Toxicol Appl Pharmacol 272:598-607
Xie, Fang; D'Agostino, Jaime; Zhou, Xin et al. (2013) Bioactivation of the nasal toxicant 2,6-dichlorobenzonitrile: an assessment of metabolic activity in human nasal mucosa and identification of indicators of exposure and potential toxicity. Chem Res Toxicol 26:388-98
Wei, Yuan; Li, Lei; Zhou, Xin et al. (2013) Generation and characterization of a novel Cyp2a(4/5)bgs-null mouse model. Drug Metab Dispos 41:132-40
Riddick, David S; Ding, Xinxin; Wolf, C Roland et al. (2013) NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology. Drug Metab Dispos 41:12-23
Wei, Yuan; Wu, Hong; Li, Lei et al. (2012) Generation and characterization of a CYP2A13/2B6/2F1-transgenic mouse model. Drug Metab Dispos 40:1144-50
Fang, C; Bolivar, V J; Gu, J et al. (2012) Neurobehavioral abnormalities in a brain-specific NADPH-cytochrome P450 reductase knockout mouse model. Neuroscience 218:170-80
Zhou, Xin; D'Agostino, Jaime; Li, Lei et al. (2012) Respective roles of CYP2A5 and CYP2F2 in the bioactivation of 3-methylindole in mouse olfactory mucosa and lung: studies using Cyp2a5-null and Cyp2f2-null mouse models. Drug Metab Dispos 40:642-7
Hough, Lindsay B; Nalwalk, Julia W; Yang, Jun et al. (2011) Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic. Pain 152:878-87
Zou, Ling; Li, Li; Porter, Todd D (2011) 7-Dehydrocholesterol reductase activity is independent of cytochrome P450 reductase. J Steroid Biochem Mol Biol 127:435-8

Showing the most recent 10 out of 70 publications